Position in HROW
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,022,125
+$557,293 QoQ
Shares Held
24,067
+82.6% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#79
of 223 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $14,352,616 across 10 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
432,956 | $6,940,284 | |
| 2 | LQDA |
Liquidia Corp
|
22,739 | $1,812,980 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
14,600 | $1,619,724 | |
| 4 | ZTS |
Zoetis Inc.
|
14,835 | $1,066,043 | |
| 5 | HROW |
Harrow, Inc.
This page
|
24,067 | $1,022,125 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
11,272 | $532,827 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
112,314 | $467,226 | |
| 8 | HLN |
Haleon plc
|
40,539 | $378,228 |
All Filings in HROW
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,022,125 | 24,067 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $464,832 | 13,183 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $703,101 | 14,349 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $681,602 | 14,147 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $439,073 | 14,377 | Shares | Sole | 2025-07-30 | |
| 2024-12-31 | $294,233 | 8,770 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $241,704 | 5,376 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||